Jean-Luc Houeto
Overview
Explore the profile of Jean-Luc Houeto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamothe H, Karachi C, Lehongre K, Buot A, Grabli D, Thobois S, et al.
Eur J Neurosci
. 2024 Oct;
60(9):6185-6194.
PMID: 39394889
Gilles de la Tourette syndrome (GTS) and dystonia (DYS) are both hyperkinetic movement disorders effectively treated by deep brain stimulation (DBS) of the internal part of the globus pallidus (GPi)....
2.
Tarrano C, Gallea C, Delorme C, McGovern E, Atkinson-Clement C, Brochard V, et al.
Sci Rep
. 2024 Sep;
14(1):22341.
PMID: 39333780
Psychiatric symptoms are common in neurodevelopmental movement disorders, including some types of dystonia. However, research has mainly focused on motor manifestations and underlying circuits. Myoclonus-dystonia is a rare and homogeneous...
3.
Tarrano C, Zito G, Gallea C, Delorme C, McGovern E, Atkinson-Clement C, et al.
Eur J Neurol
. 2024 Sep;
31(12):e16460.
PMID: 39254064
Background And Purpose: Myoclonus dystonia due to a pathogenic variant in SGCE (MYC/DYT-SGCE) is a rare condition involving a motor phenotype associating myoclonus and dystonia. Dysfunction within the networks relying...
4.
Tarrano C, Gallea C, Delorme C, McGovern E, Atkinson-Clement C, Barnham I, et al.
Brain Commun
. 2024 Apr;
6(2):fcae105.
PMID: 38601915
Non-motor aspects in dystonia are now well recognized. The sense of agency, which refers to the experience of controlling one's own actions, has been scarcely studied in dystonia, even though...
5.
Meissner W, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto J, et al.
N Engl J Med
. 2024 Apr;
390(13):1176-1185.
PMID: 38598572
Background: Lixisenatide, a glucagon-like peptide-1 receptor agonist used for the treatment of diabetes, has shown neuroprotective properties in a mouse model of Parkinson's disease. Methods: In this phase 2, double-blind,...
6.
Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carriere N, et al.
Mov Disord
. 2024 Jan;
39(3):618-622.
PMID: 38291616
Background: Acting on the main target of dopaminergic cells, the striatal γ-aminobutyric acid (GABA)-ergic cells, might be a new way to treat persons with Parkinson's disease (PD). Objective: The objective...
7.
Wirth T, Goetsch T, Corvol J, Roze E, Mariani L, Vidailhet M, et al.
J Neurol
. 2024 Jan;
271(5):2412-2422.
PMID: 38214756
Background: The long-term prognosis of impulsive compulsive disorders (ICD) remains poorly studied in Parkinson's disease (PD). Objective: Evaluating the natural history of ICD and its impact on PD symptoms including...
8.
Bereau M, Kibleur A, Servant M, Clement G, Dujardin K, Rolland A, et al.
Brain
. 2023 Oct;
147(2):472-485.
PMID: 37787488
Postoperative apathy is a frequent symptom in Parkinson's disease patients who have undergone bilateral deep brain stimulation of the subthalamic nucleus. Two main hypotheses for postoperative apathy have been suggested:...
9.
Depienne C, Ciura S, Trouillard O, Bouteiller D, Leitao E, Nava C, et al.
Tremor Other Hyperkinet Mov (N Y)
. 2023 Jul;
13:22.
PMID: 37457636
[This corrects the article DOI: 10.5334/tohm.464.].
10.
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease
Pinto S, Nebel A, Rau J, Espesser R, Maillochon P, Niebuhr O, et al.
Mov Disord
. 2022 Dec;
38(2):212-222.
PMID: 36461899
Background: The EARLYSTIM trial demonstrated for Parkinson's disease patients with early motor complications that deep brain stimulation of the subthalamic nucleus (STN-DBS) and best medical treatment (BMT) was superior to...